Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Anacor discloses positive results from phase III trials of crisaborole in atopic dermatitis

July 14, 2015

Gruenenthal reports development of CRAC inhibitors

July 9, 2015

Galderma discloses new preclinical models for neurogenic skin disorders

July 8, 2015

Novel PI3Kdelta inhibitor shows promise for the treatment of EBA

July 7, 2015

Prism Pharma begins phase I/II study of C-82 topical gel

July 7, 2015

Stelara receives European approval for adolescents with moderate to severe psoriasis

July 1, 2015

SB-204 8% is well-tolerated in subjects with acne vulgaris

June 30, 2015

RepliCel describes the potential of cell therapies to treat tendinosis and aging skin

June 29, 2015

Humira recommended for approval for hidradenitis suppurativa in E.U.

June 29, 2015

Chemokine CCR6 receptor antagonists reported in ChemoCentryx patent

June 26, 2015

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.